JN Medsys

Singapore, Singapore Founded: 2010 • Age: 16 yrs
Digital PCR instruments and consumables are developed by JN Medsys.
Annual revenue $1.8M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About JN Medsys

JN Medsys is a company based in Singapore (Singapore) founded in 2010. JN Medsys operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.

  • Headquarter Singapore, Singapore
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Jn Medsys Pte. Ltd.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.77 M (USD)
    4
    as on Dec 31, 2021
  • Net Profit
    -$102.45 K (USD)
    35
    as on Dec 31, 2021
  • EBITDA
    -$102.45 K (USD)
    35
    as on Dec 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of JN Medsys

Premium access

Detailed funding history for JN Medsys

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by JN Medsys

Investments
Premium access

Investment portfolio details for JN Medsys

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - JN Medsys

Premium access

Detailed financials for JN Medsys

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Jn Medsys Comparisons

JN Medsys Primary company
Description
Digital PCR instruments and consumables are developed by JN ...
Location
Singapore, Singapore
Founded Year
2010
Annual Revenue
$1.77 M (USD)
Net Profit
-$102.45 K (USD)
EBITDA
-$102.45 K (USD)
Employees
Not available
Premium access

Peer comparison for JN Medsys

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of JN Medsys

JN Medsys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and GenapSys, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Nanopore-based electronic systems for single-molecule analysis are developed.
Locked Locked Locked
Instrument systems and software for single-molecule real-time sequencing are developed.
Locked Locked Locked
Genome sequencing platform is provided for clinical diagnostics.
Locked Locked Locked
DNA sequencing platform for human genome analysis is developed.
Locked Locked Locked
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
Locked Locked Locked
Developer of nucleic acid detection and quantification systems
Premium access

Detailed competitors of JN Medsys

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Jn Medsys

Premium access

Complete news archive for JN Medsys

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JN Medsys

JN Medsys was founded in 2010.

JN Medsys is headquartered in Singapore, Singapore.

Annual revenue of JN Medsys is $1.77M as on Dec 31, 2021.

JN Medsys was founded in 2010 in Singapore. Digital PCR instruments and related consumables are developed by the company for use in biotechnology and diagnostics. Operations are based in Singapore, where research and manufacturing activities are conducted. Products support applications in molecular biology and clinical testing, with distribution handled through the companys domain, jnmedsys.com. The focus remains on precision tools for PCR workflows.

JN Medsys's top competitors include Nanopore, PacBio and QuantuMDx.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available